Bioidentical Hormones - U.S. Senate Special Committee on Aging
Bioidentical Hormones - U.S. Senate Special Committee on Aging Bioidentical Hormones - U.S. Senate Special Committee on Aging
127 Be:havioa fet n ntm~ orltsatrbani~njury apoetrn doe-0 * Goss CW, *Hoffm~aniSWi,!i.', *Stein ff DG. M P"" '/,..t.a"' '"i . ,' E ,*- ,..-'f X'. ': ': '- i--t --, ' '>! Department of Psychology, Emory University, Atlanta, GA 30322, USA. Evidence suggests that progesterone enhances functional recovery in rats after medial frontal cortical contusions; however, a high dose of progesterone exacerbates tissue loss in a stroke model when administered chronically (7-10 days) prior to injury [Stroke 31 (2000) 1173)]. This study attempts to determine progesterone's dose-response effects on behavioral performance and GABA-A receptor expression following a cortical contusion. Male rats received Injections of 0, 8, 16, or 32 mg/kg progesterone in 22.5% 2-hydroxypropyl-betacyclodextrin following cortical impact. Lesion 8 mg/kg and lesion 16 mg/kg groups displayed less thigmotaxis In the Morris water maze (MWM) than 0 and 32 mg/kg grquips and were n6t significantly Impaired relative to shams on other water maze measures. Increased-variability in the 32 mg/kg group during somatosensory neglect testing was the only evidence indicating that a high dose of progesterone was disruptive to a few animals. These results suggest that low and moderate doses of progesterone are optimal for facilItating recovery of select behaviors and that postinjury progesterone treatment permits a wider dose range than: preinjury treatment. Progesterone did not affect lesion size, but a strong negative correlation was observed between thalamrc GABA-A receptor density and water maze performance. Future studies could explore causes for this.relationship. PMID: 14592674 [PubMed - indexed for MEDLINE] ELUSEVIER] - Tapered progesterone withdrawal promotes Iong-termn recovery following brain traumi.' * Cutler SM, * Vanlandingham 3W, * Stein DG. Department of Emergency Medicine, Emory University, Atlanta, GA, USA. scutler@emory.edu We previously demonstrated that after traumatic brain injury (TBI), acute progesterone withdrawal (AW) causes an increase in anxiety behaviors and
128 cerebro-cellular inflammation compared to tapered progesterone withdrawal (TW). Our current study investigates the behavioral and cellular effects of AW two weeks after termination of treatments to determine the longer-term Influence of withdrawal after injury. Adult, male Sprague-Dawley rats received either bilateral frontal cortex contusion (L) or sham (S) surgery. Rats were injected at 1 and 6 h post-injury, then every 24 h for six days. Vehicle (V)treated rats were given 9 injections of 22.5% cyclodextrin, whereas AW rats received 9 Injections of 16 mg/kg progesterone and TW rats received 7. injections of P at 16 mg/kg, followed by one at 8 mg/kg and one at 4 mg/kg. On day 8, sensory neglect and locomotor activity tests were initiated. Animals were killed 22 days post-TBI and the brains prepared for either molecular or histological analysis. Western blotting revealed increased brain-derived neurotrophic factor (BDNF) and heat shock protein 70 (HSP70) in TW vs. AW animals. P53 was increased in VL animals, whereas all progesterone-treated groups were equivalent to shams. TW animals had markedly decreased sensory neglect compared to AW animals and increased center time In locomotor activity assays. In addition, lesion reconstruction revealed a decreased lesion size for TWL over AWL over VL animals. Glial fibrillary acidic protein (GFAP) immunofluorescent staining followed this pattern as well. In conclusion, after TBI, AW affects select behaviors and molecular markers in the chronic recovery period. PMID: 16797538 fPubMed - indexed for MEDLINE]
- Page 79 and 80: Statement of Loyd V. Allen, Jr., Ph
- Page 81 and 82: Statement of Loyd V. Allen, Jr., Ph
- Page 83 and 84: Statement of Loyd V. Allen, Jr., Ph
- Page 85 and 86: 82 Senator SMITH. Dr. Allen, as I h
- Page 87 and 88: 84 Now, when you are talking about
- Page 89 and 90: 86 The only thing the WHI proved wa
- Page 91 and 92: 88 Testimony Of T.S. Wiley before t
- Page 93 and 94: Confusion and Media Hype 90 Instead
- Page 95 and 96: 92 see a doctor tell a diabetic nea
- Page 97 and 98: 94 the only compelling reason to ta
- Page 99 and 100: 96 identical hormones synthesized f
- Page 101 and 102: 98 The world as we know it, from ba
- Page 103 and 104: 100 thereby experienced long period
- Page 105 and 106: 102 Bio-identical progesterone repl
- Page 107 and 108: 104 had reached optimum theoretical
- Page 109 and 110: 106 and the patient can be can reas
- Page 111 and 112: 108 Estradiol and Analytical Resear
- Page 113 and 114: 110 A controlled systematic pilot c
- Page 115 and 116: 112 of set doses. The Wiley Protoco
- Page 117 and 118: 114 I'd advocate for either Accredi
- Page 119 and 120: 116 D.C., and established a goal to
- Page 121 and 122: 118 If this legislation passes, fed
- Page 123 and 124: first and second finger on the barr
- Page 125 and 126: 122 These products that have been s
- Page 127 and 128: 124 Bcl-2, survivin and variant CD4
- Page 129: 126 These are experiments by other
- Page 133 and 134: 130 Years # women *1>0.5 8 *1+ 9 *2
- Page 135 and 136: *Breast cancer 132 -57 y.o. recurre
- Page 137 and 138: 134 *Labor intense for patient and
- Page 139 and 140: 136 Senator SMITH. Thank you very m
- Page 141 and 142: 138 makes these hormones uniquely s
- Page 143 and 144: 140 tomize the Wiley Protocol by ra
- Page 145 and 146: 142 "natural," because all lead to
- Page 147 and 148: 144 maceutical commerce, often with
- Page 149 and 150: 146 WHITE PAPER #1 DID YOU KNOW THA
- Page 151 and 152: 148 WHITE PAPER #2 Pharmacy Compoun
- Page 153 and 154: 150 bleeding of the bowel, locate t
- Page 155 and 156: 152 compounding standards can be en
- Page 157 and 158: 154 I. The FDA's definition of a "N
- Page 159 and 160: 156 ORIIGINAL CONTrMIBTION JANMA-EX
- Page 161 and 162: Initially, the design allowed women
- Page 163 and 164: ards analyses," stratified by clini
- Page 165 and 166: year). These 'drop-in" rates were a
- Page 167 and 168: years of prior use, 11 vs 2; HR, 4.
- Page 169 and 170: trogen plus progestin exposure. Clo
- Page 171 and 172: 168 RISKS AND BENEFITS OF ESTROGEN
- Page 173 and 174: EFFECTS OF POSTMENOPAUSAL ESTIROGEN
- Page 175 and 176: EFFECTS OF POSTMENOPAUSAL ESTROGEN
- Page 177 and 178: EFFECTS OF POSTMENOPAUSAL ESTROGEN
- Page 179 and 180: pEyECTS OF POSTMENOPAUSAL ESTROGEN
127<br />
Be:havioa fet n ntm~ orltsatrbani~njury apoetrn doe-0<br />
* Goss CW,<br />
*Hoffm~aniSWi,!i.',<br />
*Stein ff DG. M P""<br />
'/,..t.a"' '"i .<br />
,'<br />
E ,*- ,..-'f X'.<br />
': ': '- i--t --, ' '>!<br />
Department of Psychology, Emory University, Atlanta, GA 30322, USA.<br />
Evidence suggests that progester<strong>on</strong>e enhances functi<strong>on</strong>al recovery in rats after<br />
medial fr<strong>on</strong>tal cortical c<strong>on</strong>tusi<strong>on</strong>s; however, a high dose of progester<strong>on</strong>e<br />
exacerbates tissue loss in a stroke model when administered chr<strong>on</strong>ically (7-10<br />
days) prior to injury [Stroke 31 (2000) 1173)]. This study attempts to determine<br />
progester<strong>on</strong>e's dose-resp<strong>on</strong>se effects <strong>on</strong> behavioral performance and GABA-A<br />
receptor expressi<strong>on</strong> following a cortical c<strong>on</strong>tusi<strong>on</strong>. Male rats received Injecti<strong>on</strong>s<br />
of 0, 8, 16, or 32 mg/kg progester<strong>on</strong>e in 22.5% 2-hydroxypropyl-betacyclodextrin<br />
following cortical impact. Lesi<strong>on</strong> 8 mg/kg and lesi<strong>on</strong> 16 mg/kg<br />
groups displayed less thigmotaxis In the Morris water maze (MWM) than 0 and<br />
32 mg/kg grquips and were n6t significantly Impaired relative to shams <strong>on</strong> other<br />
water maze measures. Increased-variability in the 32 mg/kg group during<br />
somatosensory neglect testing was the <strong>on</strong>ly evidence indicating that a high dose<br />
of progester<strong>on</strong>e was disruptive to a few animals. These results suggest that low<br />
and moderate doses of progester<strong>on</strong>e are optimal for facilItating recovery of<br />
select behaviors and that postinjury progester<strong>on</strong>e treatment permits a wider<br />
dose range than: preinjury treatment. Progester<strong>on</strong>e did not affect lesi<strong>on</strong> size, but<br />
a str<strong>on</strong>g negative correlati<strong>on</strong> was observed between thalamrc GABA-A receptor<br />
density and water maze performance. Future studies could explore causes for<br />
this.relati<strong>on</strong>ship.<br />
PMID: 14592674 [PubMed - indexed for MEDLINE]<br />
ELUSEVIER] -<br />
Tapered progester<strong>on</strong>e withdrawal promotes I<strong>on</strong>g-termn recovery following brain<br />
traumi.'<br />
* Cutler SM,<br />
* Vanlandingham 3W,<br />
* Stein DG.<br />
Department of Emergency Medicine, Emory University, Atlanta, GA, USA.<br />
scutler@emory.edu<br />
We previously dem<strong>on</strong>strated that after traumatic brain injury (TBI), acute<br />
progester<strong>on</strong>e withdrawal (AW) causes an increase in anxiety behaviors and